Stephen Freedland MD

Stephen Freedland, MD, is director of the Center for Integrated Research in Cancer and Lifestyle and associate director for Training and Education at the Samuel Oschin Comprehensive Cancer Institute. He is the Warschaw, Robertson, Law Families Chair in Prostate Cancer and professor in the Department of Urology at Cedars-Sinai. Freedland's clinical expertise focuses on urological diseases, particularly benign prostatic hyperplasia and prostate cancer. His approach toward cancer prevention and awareness focuses on treating the whole patient, not just the disease, by combining traditional Western medicine with complementary holistic interventions.

His research interests include urological diseases and the role of diet, lifestyle, and obesity in prostate cancer development and progression, as well as prostate cancer among racial groups and risk stratification for men with prostate cancer. Freedland has published over 700 studies, and his research has appeared in the Journal of the American Medical Association, Journal of the National Cancer Institute, Journal of Clinical Oncology, Journal of Urology, Cancer Prevention Research, Cancer and BJUI, among others. Freedland is an active reviewer for more than 50 journals.

He sits on the editorial board for Cancer Prevention Research, International Journal of Urology, Nature Reviews Urology, Asian Journal of Andrology, and serves as editor-emeritus for Prostate Cancer and Prostatic Diseases. Freedland earned his MD from the University of California, Davis. He completed a residency in urology at UCLA and a fellowship in urological oncology at Johns Hopkins. Before joining Cedars-Sinai, he was at Duke University, where he specialized in surgical oncology and urologic oncology, and served as an associate professor in the Division of Urology.